Home

Gland Pharma PE Ratio

Image

Gland Pharma Ltd

NSE: GLAND

PE

43.8

Last updated on: Jul 13, 2025

Key Highlights

  • The P/E Ratio of Gland Pharma Ltd is 43.8 as of 13 Jul 9.00 AM .
  • The P/E Ratio of Gland Pharma Ltd changed from 40.7 on March 2021 to 39.3 on March 2024 . This represents a CAGR of -0.87% over 4 years.
  • The Latest Trading Price of Gland Pharma Ltd is ₹ 1859 as of 11 Jul 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 14.5. The PE Ratio of Finance industry is 27.9. The PE Ratio of IT - Software industry is 27.0. The PE Ratio of Pharmaceuticals industry is 33.9. The PE Ratio of Retail industry is 109.6. The PE Ratio of Textiles industry is 24.5 in 2025.

Historical P/E Ratio of Gland Pharma Ltd

No data available

Company Fundamentals for Gland Pharma Ltd

Image

Gland Pharma Ltd

NSE: GLAND

Share Price

₹ 1859.05

16.45 (0.89%)

stock direction

Last updated on: Jul 11, 2025

Market Price of Gland Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Gland Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Jul 20251859.05
10 Jul 20251842.6
09 Jul 20251878.2
08 Jul 20251887.6
07 Jul 20251875.65
04 Jul 20251873.85
03 Jul 20251874
02 Jul 20251865.85
01 Jul 20251876.7
30 Jun 20251831.95

SWOT Analysis Of Gland Pharma Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Gland Pharma Ltd

Asset Value vs Market Value of Gland Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Gland Pharma Ltd30629
Sun Pharmaceutical Industries Ltd401289
Divis Laboratories Ltd181397
Cipla Ltd119949
Torrent Pharmaceuticals Ltd112127
Mankind Pharma Ltd106401

PE Ratio of Gland Pharma Ltd Explained

30629

Market cap

698

Earnings

43.8X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Gland Pharma Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Gland Pharma Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Gland Pharma Ltd

No data available

* All values are in %

About Gland Pharma Ltd

  • Gland Pharma Limited was incorporated as Gland Pharma Private Limited', a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
  • Subsequently, the name of the Company was changed to Gland Pharma Limited' and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
  • The Company is primarily engaged in manufacturing injectable formulations. The company is one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019.
  • The company has 8 manufacturing facilities in India, comprising four finished formulations facilities with a total of 23 production lines and three API facilities.

Gland Pharma Ltd News Hub

Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr

Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before tax (PBT) s

Read more

07 Aug 24

Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter

Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as agai

Read more

06 Aug 24

US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility

The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspection was c

Read more

05 Aug 24

Gland Pharma Ltd gains for third straight session

Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1936.35, up 1

Read more

09 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Gland Pharma Ltd

What is the current PE Ratio of Gland Pharma Ltd?

The Current PE Ratio of Gland Pharma Ltd is 43.85 as on 13 Jul 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 33.9 as on 13 Jul 2025.

What was the PE Ratio of Gland Pharma Ltd last year?

The PE Ratio of Gland Pharma Ltd was 26.75 last year, now the PE ratio is 43.85, showing a year-on-year growth of 63.9%.

What does the PE Ratio of Gland Pharma Ltd indicate about its stock?

The PE Ratio of Gland Pharma Ltd is 43.85. This ratio indicates that investors are willing to pay 43.85 times the earnings per share for each share of Gland Pharma Ltd.

What is the PE Ratio Growth of Gland Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Gland Pharma Ltd grew by 63.9% whereas, the EPS ratio grew by -8.9.

How does the PE ratio of Gland Pharma Ltd compare to industry peers?

The PE ratio of Gland Pharma Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Gland Pharma Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Gland Pharma Ltd PE Ratio.

What factors influence the PE ratio of Gland Pharma Ltd PE Ratio?

The PE ratio of Gland Pharma Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Gland Pharma Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Gland Pharma Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Gland Pharma Ltd PE Ratio?

You can check the latest PE ratio of Gland Pharma Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Gland Pharma Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Gland Pharma Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Gland Pharma Ltd PE Ratio predict future stock performance?

While the Gland Pharma Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions